Tuberculosis prophylaxis in patients with steroid treatment and systemic rheumatic diseases. A case-control study

Clinical and Experimental Rheumatology

Volumn 17, Issue 1, 1999, Pages 81-87

  Hernandez Cruz B ^a   Ponce de Leon Rosales S ^a   Sifuentes Osornio, J ^a   Ponce de Leon Garduno A ^a   Diaz Jouanen E ^a  

^a INSTITUTO NACIONAL DE CIENCIAS MÉDICAS Y NUTRICIÓN SALVADOR ZUBIRÁN   (Mexico)

Author keywords

Isoniazid; Prophylaxis; Rheumatic diseases; SLE; Tuberculosis

Indexed keywords

AZATHIOPRINE; CYCLOPHOSPHAMIDE; ISONIAZID; MERCAPTOPURINE; METHOTREXATE; PREDNISONE; STEROID;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; MALE; PREVALENCE; PRIORITY JOURNAL; RHEUMATIC DISEASE; RISK FACTOR; TUBERCULOSIS; TUBERCULOSIS CONTROL;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTIBIOTIC PROPHYLAXIS; ANTITUBERCULAR AGENTS; CASE-CONTROL STUDIES; CHILD; FEMALE; GLUCOCORTICOIDS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; ISONIAZID; MALE; MIDDLE AGED; ODDS RATIO; PREDNISOLONE; RHEUMATIC DISEASES; TUBERCULOSIS;

EID: 0344334030     PISSN: 0392856X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. STAPLES PJ, GERDING DN, DECKER JL, GORDON RS: Incidence of infection in systemic lupus erythemalosus. Arthritis Rheum 1974; 17: 1-10.
2. MILLAR JW, HORNE NW: Tuberculosis in immunosuppressed patients. Lancet 1979; i: 1176-8.
3. GINZLER E, DIAMOND H, KAPLAN D, WEINER M, SCHLESMERG M, SELEZNlCK M: Computer analysis of factors influencing frequency of infection in systemic lupus erythematosus. Arthritis Rheum 1978; 21: 37-44.
4. FENGH PH, TAN TH: Tuberculosis in patients with systemic lupus erythematosus. Ann Rheum Dis 1982; 41: 11-14.
5. TERESA SG, VICTORIO-NAVARRA, EDWIN ER, ARROLLO GC, TORRALBA TP: Tuberculosis among Filipino patients with systemic lupus erythematosus. Semin Arthritis Rheum 1996; 26: 628-34.
6. AMERICAN THORACIC SOCIETY (Medical Section of the American Lung Association): Treatment of tuberculosis and tuberculosis infection in adults and children. Am Rev Resp Dis 1986; 134: 355-63.
7. SCHATZ M, PATTERSON R, KLONER R, FALK J: The prevalence of tuberculosis and positive tuberculin skin test in a steroid-treated asthmatic population. Ann Intern Med 1976; 84: 261-65.
8. BLOCK S, GIBBS C, STEVENS M, SCHULMAN L: Delayed hypersensitivity in systemic lupus erythematosus. Ann Rheum Dis 1968; 27: 311-18.
9. Epidemiologiá. Sistema Unico de Informatión. Sistema Nacional de Vigilancia Epidemiológica. Secretaría de Salud 1996; 51: 6.
10. Mortalidad. Dirección General de Estadística e Informática. Subsecretaría de Prevención y Control de Enfermedades. Secretaría de Salud, 1996.
11. GARCÍA-GARCÍA ML, VALDESPINO-GÓMEZ JL, GARCÍA-SANCHO MC, SALCEDO-ALVAREZ RA: Epidemiología de VIH/SIDA y tuberculosis. In: SADA DIAZ E and SIFUENTES OSORNIO J (Eds.): Tuberculosis. Mexico, Interamericana-MacGraw Hill, 1995; 809-22.
12. Table G. Random numbers table. In DANIEL (Ed.): Biostatistics: A Foundation for Analysis in the Health Sciences. 3rd ed., John Wiley & Sons, 1987; 623.
13. KNAPP T: A methodological critique of the ideal weight concept. JAMA 1983; 250: 506-10.
14. TAN EM, COHEN AS, FRIES JF et al.: The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982; 25: 1271-7.
15. ARNETT FC, EDWORTHY SM, BLOCH DA et al.: The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthrtitis Rheum 1998; 31: 315-24.
16. BOHAN A, PETER J: Polymyositis and dermatomyositis. N Engl J Med 1975; 292; 344-7, 403-7.
17. ALARCON-SEGOVIA D, VILLARREAL M: Classification and diagnostic criteria for mixed connective tissue disease. In: KASUKAWA R and SHARP GC (Eds.): Mixed Connective Tissue Disease and Antinuclear Antibodies. Amsterdam, Elsevier Science Publishers B.V. Biomedical Division 1987; 33-40.
18. MILLS J, MICHEL B, BLOCH D et al.: The American College of Rheumatology 1990 criteria for the classification of Henoch-Schönlein purpura. Arthritis Rheum 1990; 33: 1114-21.
19. LEAVITT R, FAUCI A, BLOCH D et al.: The American College of Rheumatology 1990 criteria for the classification of Wegener's granulomatosis. Arthritis Rheum 1990; 33: 1101-7.
20. SUBCOMMITTEE FOR SCLERODERMA CRITERIA. American Rheumatism Association Diagnostic and Therapeutic Criteria Committee: Preliminary criteria for the classification of systemic sclerosis (scleroderma). Arthri-tis Rheum 1980; 23: 581-90.
21. DES PREZ RM, HEIM CR: Mycobacterium tuberculosis. In: MANDELL GL, DOUGLAS RG and BENNET JE: Principles and Practice of Infectious Diseases. 3rd ed., New York, Churchill Livingstone 1990: 1877-906.
22. ROBERTS GL, KONEMAN EW, KIMM YK: Mycobacterium. In: BALOWS A, HAUSLER WJ Jr, HERRMANN KL, ISENBERG HD, and SHADOMY JH: Manual of Clinical Microbiology. 5th ed., Washington, American Society for Microbiology, 1991: 304-39.
23. SCHLESSELMAN JJ: Case Control Studies. Design, Conduct, Analysis. New York, Oxford University Press 1982: 171-226.
24. KAHN HA, SEMPOS CT: Statistical Methods in Epidemiology. New York. Oxford University Press, 1989: 137-67.
25. Computing Resource Center: StaTa Statistics/ Data Analysis. 3.0 1992. 1640 Fifth Street. Santa Monica, CA.
26. SELBY J: Case control evaluations of treatment and program efficacy. Epidemiologic Reviews 1994; 16: 90-101.
27. JEREB JA, CAUTHEN GM, KELLY GD, GEITER LJ: The epidemiology of tuberculosis. In LLOYD N and FRIEDMAN (Eds.): Tuberculosis Current Concepts and Treatment. CRC Press 1994: 1-26.
28. GUYATT G, SACKETT D, COOK D: Users' guides to the medical literature. II. How to use an article about therapy or prevention. B. What were the results and will they help me in caring for my patients ? JAMA 1994; 271: 59-63.
29. KOPANOFF D, SNIDER D, CARAS G: Isoniazid-related hepatitis. A U.S. Public Health Service cooperative surveillance study. Am Rev Resp Dis 1978; 117: 991-1001.
30. STERNE JA, RODRIGUEZ LC, GUEDES IN: Does the eficacy of BCG decline with time since the vaccination ? Int J Tuberc Lung Dis 1998; 2: 200-7.